Physician profile
Stephen D Anesi
NPI 1003052788
$921,613.73
in general payments reported to CMS, 2019-2025
41 companies · $142K in 2025
The $142K reported for 2025 was more than what 99% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136K · 2020: $69K · 2021: $107K · 2022: $135K · 2023: $142K · 2024: $191K · 2025: $142K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $342K · Honoraria: $48K · Consulting Fee: $33K · Travel and Lodging: $25K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,188 · Education: $97.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $342,392.50 |
| Honoraria | $48,100.00 |
| Consulting Fee | $32,950.00 |
| Travel and Lodging | $24,713.31 |
| Food and Beverage | $19,363.37 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,187.50 |
| Education | $97.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $616,327.11 | 2020-2025 | Acthar |
| Mallinckrodt Enterprises LLC | $119,103.92 | 2019 | |
| Eyepoint US, INC. | $44,059.92 | 2019-2024 | |
| Bausch & Lomb Americas INC. | $34,601.36 | 2022-2025 | Xipere, Xiidra, Miebo |
| Abbvie INC. | $31,298.55 | 2019-2025 | Durysta, Ozurdex, Xen Glaucoma Treatment System |
| Alimera Sciences, INC. | $28,787.61 | 2019-2024 | Iluvien, Yutiq |
| Ani Pharmaceuticals, INC. | $24,086.34 | 2022-2025 | Purified Cortrophin Gel, Iluvien, Yutiq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $8,175.97 | 2022-2023 | |
| Horizon Therapeutics Plc | $3,291.57 | 2021-2023 | Tepezza |
| Sight Sciences, INC. | $2,349.92 | 2019-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $1,340.07 | 2019-2025 | Clareon, Clareon Panoptix Pro, Lensx |
| Allergan, INC. | $948.78 | 2019-2022 | |
| Oyster Point Pharma, INC. | $705.32 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Beaver-Visitec International, INC. | $650.00 | 2022 | |
| Sun Pharmaceutical Industries INC. | $627.22 | 2019-2025 | Cequa |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $543.32 | 2024-2025 | Xdemvy |
| Dompe US, INC. | $483.03 | 2019-2025 | Oxervate |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $462.29 | 2019-2021 | |
| Ocular Therapeutix, INC. | $357.35 | 2020-2025 | Dextenza |
| Regeneron Healthcare Solutions, INC. | $357.26 | 2022-2025 | Eylea Hd |
| Samsara Vision | $334.18 | 2025 | Implantable Miniature Telescope (Imt By Dr. Isaac Lipshitz) |
| Genentech USA, INC. | $325.30 | 2023-2024 | Vabysmo |
| Aerie Pharmaceuticals, INC. | $310.26 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $275.70 | 2019-2021 | |
| Biotissue Holdings INC. | $254.84 | 2019-2025 | |
| New World Medical,INC. | $243.40 | 2021-2025 | Clearpath, Ahmed Glaucoma Valve, Kahook Dual Blade |
| Novartis Pharmaceuticals Corporation | $228.43 | 2019-2023 | |
| Amgen INC. | $222.25 | 2024-2025 | Tepezza, Uplizna, Tavneos |
| Harrow Eye, LLC | $198.68 | 2024 | Iheezo, Vevye |
| Astellas Pharma US INC | $112.24 | 2023-2025 | Izervay |
| Eyevance Pharmaceuticals LLC | $104.88 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $87.34 | 2022 | |
| Thea Pharma INC. | $73.07 | 2024-2025 | Iyuzeh |
| Coherus Oncology, INC. | $66.72 | 2022-2023 | |
| Rayner Intraocular Lenses Limited | $56.89 | 2023-2025 | Omidria, Rayone Emv, Rayone Aspheric |
| Dutch Ophthalmic, USA | $43.73 | 2024 | Eva, Combined Machine, Tissueblue |
| Glaukos Corporation | $35.56 | 2019-2024 | Idose |
| Organon LLC | $26.33 | 2025 | Hadlima |
| Shire North American Group INC | $23.82 | 2019 | |
| Apellis Pharmaceuticals, INC. | $19.83 | 2023 | Syfovre |
| Ivantis, INC | $13.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Anesi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.